Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Jiuding Capital Launches PE Fund for China Pharma

publication date: Nov 27, 2009
Kunwu Jiuding Capital Co., Ltd. of Beijing has launched a private equity investment fund focused on China’s pharmaceutical industry. Jiuding Capital says the fund, known as Kunwu Jiuding Pharmaceutical Investment Management Co., Ltd., is the first PE fund specifically devoted to the sector. Jiuding Capital expects Fund I to have 500 million RMB ($74 million) fund. Raising the money will not be a problem as committed capital already exceeds one billion RMB ($150 million). More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital